DUBLIN--(BUSINESS WIRE)--The "Global Rheumatology Therapeutics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.
The Global Rheumatology Therapeutics Market is projected to grow at a CAGR of 4.24% during the period 2018-2022.
One trend affecting this market is the rising number of small molecules in the drug development pipeline. The global rheumatology therapeutics is witnessing a significant increase in the number of small molecules in the drug development phase.
According to the report, one driver influencing this market is the increasing prevalence of rheumatic disorders. The global rheumatology therapeutics market is expected to witness a rapid growth due to increasing cases if rheumatic disorders.
Further, the report states that one challenge affecting this market are product rejections and discontinuation. Stringent government regulations for the approval of new drugs and biologics for the treatment of rheumatological diseases is expected to pose a challenge for the growth of the market.
Market Trends
- Rising Number of Small Molecules in the Drug Development Pipeline
- Strategic Alliances
- Increasing Patient Support Programs
Key Vendors
- AbbVie
- Amgen
- Janssen Pharmaceuticals
- Pfizer
- UCB
Topics Covered
1. Executive Summary
2. Scope of the Report
3. Research Methodology
4. Market Landscape
5. Market Sizing
6. Five Forces Analysis
7. Pipeline Landscape
8. Market Segmentation by Molecule Type
9. Regional Landscape
10. Customer Landscape
11. Decision Framework
12. Drivers and Challenges
13. Market Trends
14. Vendor Landscape
15. Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/j23bd7/global?w=4
